APA (7th ed.) Citation

Bissonnette, R., Poulin, Y., Zhou, Y., Tan, J., Hong, H., Webster, J., . . . Lyle, M. (2012). Efficacy and safety of topical WBI-1001 in patients with mild to severe atopic dermatitis: Results from a 12-week, multicentre, randomized, placebo-controlled double-blind trial. British Journal of Dermatology, 166(4), 853. https://doi.org/10.1111/j.1365-2133.2011.10775.x

Chicago Style (17th ed.) Citation

Bissonnette, R., Y. Poulin, Y. Zhou, J. Tan, H.C Hong, J. Webster, W. Ip, L. Tang, and M. Lyle. "Efficacy and Safety of Topical WBI-1001 in Patients with Mild to Severe Atopic Dermatitis: Results from a 12-week, Multicentre, Randomized, Placebo-controlled Double-blind Trial." British Journal of Dermatology 166, no. 4 (2012): 853. https://doi.org/10.1111/j.1365-2133.2011.10775.x.

MLA (9th ed.) Citation

Bissonnette, R., et al. "Efficacy and Safety of Topical WBI-1001 in Patients with Mild to Severe Atopic Dermatitis: Results from a 12-week, Multicentre, Randomized, Placebo-controlled Double-blind Trial." British Journal of Dermatology, vol. 166, no. 4, 2012, p. 853, https://doi.org/10.1111/j.1365-2133.2011.10775.x.